{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T21:10:07Z","timestamp":1770757807612,"version":"3.50.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"DOI":"10.7759\/cureus.103359","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:26:15Z","timestamp":1770740775000},"source":"Crossref","is-referenced-by-count":0,"title":["Myocardial Infarction in an Ironman Triathlete: A Case for Advanced Lipid Testing in Cardiovascular Risk Assessment"],"prefix":"10.7759","author":[{"given":"Matt","family":"Mackler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Rocic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","unstructured":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023. a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025, 406:1811-72. 10.1016\/S0140-6736(25)01917-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams KJ","year":"1995","unstructured":"Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995, 15:551-61. 10.1161\/01.atv.15.5.551","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas I","year":"2007","unstructured":"Tabas I, Williams KJ, Bor\u00e9n J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 2007, 116:1832-44. 10.1161\/CIRCULATIONAHA.106.676890","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby P","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002, 420:868-74. 10.1038\/nature01323","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf594","article-title":"Therapies leading to coronary atherosclerosis plaque regression: a scientific statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging of the ESC, the ESC Working Group on Atherosclerosis and Vascular Biology, and the ESC Working Group on Cardiovascular Pharmacotherapy Part 1: Atherosclerosis Pathophysiology and Imaging Evaluation","author":"Conte E","year":"2025","unstructured":"Conte E, Perone F, Cosyns B, et al.. Therapies leading to coronary atherosclerosis plaque regression: a scientific statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging of the ESC, the ESC Working Group on Atherosclerosis and Vascular Biology, and the ESC Working Group on Cardiovascular Pharmacotherapy Part 1: Atherosclerosis Pathophysiology and Imaging Evaluation. Eur J Prev Cardiol. 2025, 10.1093\/eurjpc\/zwaf594","journal-title":"Eur J Prev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-004-0050-5","article-title":"Low-density lipoprotein particle number and risk for cardiovascular disease","volume":"6","author":"Cromwell WC","year":"2004","unstructured":"Cromwell WC, Otvos JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep. 2004, 6:381-7. 10.1007\/s11883-004-0050-5","journal-title":"Curr Atheroscler Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference BA","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, et al.. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017, 38:2459-72. 10.1093\/eurheartj\/ehx144","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy SM","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al.. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019, 139:e1082-143. 10.1161\/CIR.0000000000000625","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman AD","year":"2019","unstructured":"Sniderman AD, Thanassoulis G, Glavinovic T, Navar AM, Pencina M, Catapano A, Ference BA. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019, 4:1287-95. 10.1001\/jamacardio.2019.3780","journal-title":"JAMA Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016857","article-title":"Atherogenic lipoprotein subfractions determined by ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial","volume":"132","author":"Mora S","year":"2015","unstructured":"Mora S, Caulfield MP, Wohlgemuth J, et al.. Atherogenic lipoprotein subfractions determined by ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial. Circulation. 2015, 132:2220-9. 10.1161\/CIRCULATIONAHA.115.016857","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae258","article-title":"Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention","volume":"45","author":"Sniderman AD","year":"2024","unstructured":"Sniderman AD, Dufresne L, Pencina KM, Bilgic S, Thanassoulis G, Pencina MJ. Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention. Eur Heart J. 2024, 45:2410-8. 10.1093\/eurheartj\/ehae258","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.027834","article-title":"Relationship between lifelong endurance exercise and coronary atherosclerosis in athletes","volume":"136","author":"Aengevaeren VL","year":"2017","unstructured":"Aengevaeren VL, Mosterd A, Braber TL, et al.. Relationship between lifelong endurance exercise and coronary atherosclerosis in athletes. Circulation. 2017, 136:138-48. 10.1161\/CIRCULATIONAHA.117.027834","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32833b7756","article-title":"Lipoprotein subfractions and cardiovascular disease risk","volume":"21","author":"Krauss RM","year":"2010","unstructured":"Krauss RM. Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol. 2010, 21:305-11. 10.1097\/MOL.0b013e32833b7756","journal-title":"Curr Opin Lipidol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low-density lipoprotein subclass patterns and risk of myocardial infarction","volume":"260","author":"Austin MA","year":"1988","unstructured":"Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988, 260:1917-21.","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90144-E","article-title":"Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype pattern B","volume":"94","author":"Chait A","year":"1993","unstructured":"Chait A, Brazg RL, Tribble DL. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype pattern B. Am J Med. 1993, 94:350-6. 10.1016\/0002-9343(93)90144-E","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.04.005","article-title":"Potential adverse cardiovascular effects from excessive endurance exercise","volume":"87","author":"O'Keefe JH","year":"2012","unstructured":"O'Keefe JH, Patil HR, Lavie CJ, Magalski A, Vogel RA, McCullough PA. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc. 2012, 87:587-95. 10.1016\/j.mayocp.2012.04.005","journal-title":"Mayo Clin Proc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303458","article-title":"All low-density lipoprotein particles are not created equal","volume":"34","author":"Krauss RM","year":"2014","unstructured":"Krauss RM. All low-density lipoprotein particles are not created equal. Arterioscler Thromb Vasc Biol. 2014, 34:959-61. 10.1161\/ATVBAHA.114.303458","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)08415-9","article-title":"Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview","volume":"355","author":"Capes SE","year":"2000","unstructured":"Capes SE, Hunt D, Malmberg K, et al.. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000, 355:773-8. 10.1016\/S0140-6736(99)08415-9","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462160-myocardial-infarction-in-an-ironman-triathlete-a-case-for-advanced-lipid-testing-in-cardiovascular-risk-assessment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:26:16Z","timestamp":1770740776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462160-myocardial-infarction-in-an-ironman-triathlete-a-case-for-advanced-lipid-testing-in-cardiovascular-risk-assessment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.103359","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}